Edition:
United States

Profile: Veloxis Pharmaceuticals A/S (VELOX.CO)

VELOX.CO on Copenhagen Stock Exchange

0.85DKK
23 Nov 2017
Change (% chg)

kr.-0.03 (-2.87%)
Prev Close
kr.0.87
Open
kr.0.86
Day's High
kr.0.87
Day's Low
kr.0.85
Volume
723,315
Avg. Vol
868,954
52-wk High
kr.1.28
52-wk Low
kr.0.84

Veloxis Pharmaceuticals A/S, formerly LifeCycle Pharma A/S, is a Denmark-based commercial-stage specialty pharmaceutical company. The Company operates in the United States (US) through its subsidiary, Veloxis Pharmaceuticals Inc, based in Cary, North Carolina, US. The Company’s products include: Envarsus XR (tacrolimus extended-release tablets), a prescription medicine used with other medicines to help prevent organ rejection in people who have had a kidney transplant, as well as Fenoglide for the treatment of dyslipidemia in the United States. Envarsus XR is based upon the Company's patented delivery technology, MeltDose, which is designed to help the absorption and bioavailability of select orally administered drugs.

Company Address

Veloxis Pharmaceuticals A/S

Amerika Plads 37
COPENHAGEN OE     2100

Company Web Links